HOME >> MEDICINE >> NEWS
Expert calls for common sense, science in national response to medicinal herbs

CHAPEL HILL -- Because plants have been used to treat illness since before modern humans evolved and will remain popular into the foreseeable future, the nation needs to combine common sense with good science in its response to medicinal herbs.

That's the view of Dr. Varro E. Tyler, one of the world's leading experts on the subject.

"In my opinion, this is a scandalous situation," Tyler said. "Here we have products that are used by one-third of the adult population in the United States with a retail annual market value approximating $4 billion, and the FDA, by establishing artificially high proof-of-efficacy hurdles, refuses them drug approval. Compare this with the situation that has worked so well in Germany for many years in which 'reasonable' amounts of proof are accepted as evidence of efficacy for phytomedicines, allowing the products to become an integral part of mainstream medicine."

Author of more than 30 books, Tyler is distinguished professor emeritus of pharmacognosy at Purdue University and dean of pharmacy emeritus. He spoke Thursday (March 2) at the University of North Carolina at Chapel Hill at the first international scientific conference on medicinal herbs.

"The ancient origins of herbal medicine are indisputable," he said.

Archaeologists have found pollen and flower fragments from different medicinal plants in Neanderthal tombs in Iraq dating back some 60,000 years, the scholar said. Cannabis -- the marijuana plant -- is believed to have been used for more than 8,000 years in China, and opium, first produced in Mesopotamia, has been an important painkiller for some 5,400.

"The mummified human discovered in the Italian Alps in 1991 and now referred to as 'the iceman' possessed two pieces of birch fungus," Tyler said. "Scientists speculate that this 5,300-year-old human was using the fungus as a drug, possibly as a treatment for intestinal parasites."

The golden age of herbal medicine in the United States straddled th
'"/>

Contact: David Williamson
david_williamson@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
1-Mar-2000


Page: 1 2 3 4

Related medicine news :

1. Expert panel calls for raising the bar in treating schizophrenia
2. Experts debate benefits, dangers of chlorine in C&EN point-counterpoint
3. Expert nurse paves the way with in-demand treatment option; Century-old brachytherapy rejuvenated
4. Expert calls for standard epinephrine doses when treating children in cardiac arrest
5. Experts to discuss new advances in IBS therapy and its affect on IBS sufferers
6. Experts to discuss emerging technologies in GI diagnosis and treatment
7. Experts to discuss the affects of non-steroidal anti-inflammatory drugs (NSAIDs)
8. Experts present new research on the hot topics of aging at GSAs Annual Meeting
9. Expert reviews cannot be trusted
10. Experts welcome major reforms to the coroners service
11. Experts meet to challenge approaches of testing and developing cancer treatments

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... January 19, 2017 , ... Dr. Andrew Lian-Jie ... fellowship trained Mohs and cosmetic surgeon. After extensive dermatology research training at the ... internship in internal medicine at the Emory University and dermatology training at the ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... treatments for patients with sleep apnea and TMJ disorders. These conditions are quite ... health. Dr. Rassouli provides personalized care to reduce the risk of these consequences ...
(Date:1/19/2017)... ... 19, 2017 , ... Rountree Brady Insurance Agency, a Savannah ... eastern Georgia, is embarking on a charity effort to raise awareness and gather ... every year than anything else, yet risk factors associated with heart disease are ...
(Date:1/19/2017)... ... January 19, 2017 , ... Creative messages to prevent distracted ... from Impact Teen Drivers and California Casualty. Entries from students aged 14-22 can ... totaling $15,000 will be awarded for the best peer-to-peer messages sharing solutions to ...
(Date:1/19/2017)... ... ... The 21st Century Cures Act’s Impact on Medical Devices:, What You Need ... p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          , What do manufacturers ... year? , The passage of the act means devicemakers will be scrambling to meet ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... -- Shire plc (LSE: SHP, NASDAQ: ... Drug Administration (FDA) has acknowledged receipt of the Class ... SHP465, a long-acting, triple-bead, mixed amphetamine salts formulation. SHP465 ... Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected to provide ... designated Prescription Drug User Fee Act (PDUFA) action date. ...
(Date:1/19/2017)... , January 19, 2017 ... administration appears serious about reducing the FDA,s regulatory ... innovation in the medical drug industry, many of ... with new clinical trials and development of advanced ... forging ahead with recent developments include:  Moleculin Biotech, ...
(Date:1/19/2017)... The Global Therapy Partnering Terms and Agreements since 2010 ... agreements entered into by the world,s leading healthcare companies. ... by value - Deals listed by company A-Z, industry ... provides understanding and access to the partnering deals and ... The report provides an analysis of partnering deals. ...
Breaking Medicine Technology:
Cached News: